GABAPENTIN
- Product NDC
- 43063-759
- 11-digit product format
- 430630759
- Labeler code
- 43063
- Product ID
- 43063-759_adccc28d-7112-43f4-e053-2995a90a8a58
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA204989
- Marketing category
- ANDA
- Marketing start
- 2016-09-30
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 43063-759-28 | EA - Each | 43063-759 | c94e4499-77b5-4aa8-8417-67ba58b4f5bd | 1 | 2019-11-12 |
| 43063-759-30 | EA - Each | 43063-759 | 149ca144-4409-4ba5-9953-2fbabf04f113 | 1 | 2017-06-15 |
| 43063-759-45 | EA - Each | 43063-759 | af741f95-5289-41e4-b1b3-a24d735fffc4 | 1 | 2019-03-12 |
| 43063-759-60 | EA - Each | 43063-759 | 33c1cb3a-8593-4dba-b963-fff699f71bcd | 1 | 2017-06-15 |
| 43063-759-83 | EA - Each | 43063-759 | b04ed12f-6c0e-4af9-b181-53c27d51c64c | 1 | 2017-06-15 |
| 43063-759-86 | EA - Each | 43063-759 | c95542a0-b413-4a84-a259-2a4c5669c3b7 | 1 | 2017-06-15 |
| 43063-759-90 | EA - Each | 43063-759 | d7cb3658-fd2d-4557-8ea9-0f8d48210038 | 1 | 2017-06-15 |
| 43063-759-93 | EA - Each | 43063-759 | 29b4a3b9-d875-46a0-95eb-a2314ef779a3 | 1 | 2017-06-15 |
| 43063-759-94 | EA - Each | 43063-759 | 7894a149-84dc-45b2-81a9-6f482952f5a2 | 1 | 2017-06-15 |